LIFE-CHANGING INNOVATIONS
About us
Mission
Our mission is to make cutting-edge cell and gene therapies accessible and affordable for those in need. By harnessing the power of AI and advanced biotechnology, we accelerate the development of innovative, life-changing treatments for complex diseases. We are committed to removing barriers in healthcare and ensuring that breakthrough therapies are practically accessible to everyone.
Vision
To lead the next generation of AI-powered healthcare solutions through biotechnology, transforming lives by making advanced therapies affordable and accessible through innovation and excellence.
Core Values
Innovation: We push the boundaries of science and technology to develop groundbreaking therapies.
Accessibility: We focus on making novel healthcare advances available to people globally.
Integrity: We operate with transparency, ethics, and respect in every aspect of our work.
Collaboration: We foster partnerships and work as a team to tackle the world’s toughest healthcare challenges.
Excellence: We strive for high quality in our research and development to improve patient care standards.
Leadership
Paul Michael Hallelujah MTS
(Co-Founder & Chief Executive Officer):
Leading Vaxx’s mission to develop transformative healthcare solutions for the global population. A Gold Medalist in Queen's University's Biology program and a top-ten student in his Electrical Engineering class (Queen's), Paul studied medicine for 4 years (U of Alberta, Queen's) before completing his MTS from U of Toronto. He has filed a patent on the methodology for HIV cure.
George Estafanos MHA, MBBCh (MD), CHIM
(Co-founder & Chief Operating Officer)
A trained physician with experience in clinical management, informatics, regulatory affairs, and research, he is integral to advancing Vaxx’s innovation and ensuring compliance with industry standards.
Suraj Abraham M.Eng., Ph.D
(Co-Founder & Chief Scientific Officer)
A pharmaceutical scientist & biotech expert with over a decade of product development experience in cell & gene therapy and biologics manufacturing. USASK Ph.D graduate, Ex-BITSIAN and Ex-Danaher (Cytiva/Pall Life Sciences/Precision NanoSystems) technical lead and people leader. As our Chief Scientist, Dr Abraham leads Vaxx's proprietary cell & gene therapy platform development and manages Vaxx's innovation engine.